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ABSTRACT 
Insulin (INS) was encapsulated into complexes with poly(ethylene glycol)-block-
poly(L-lysine) (PEG-b-PLys), which is a polypeptide-based block copolymer (a 
neutral-cationic block polyelectrolyte). These macromolecules can encapsulate INS 
molecules in aqueous conditions via electrostatic interactions. Light scattering 
techniques are used in order to examine the complexation process of the hybrid 
nanoparticles in a gamut of buffers, as a function of protein concnetration. The 
physicochemical and structural characteristics of the complexes depend on the ionic 
strength of the aqueous medium, while the concentration of PEG-b-PLys was constant 
through the series of solutions. As INS concentration increased each polyelectrolyte 
chain interacts with an increasing number of INS molecules, the degree of charge 
neutralization becomes higher and the size distribution of the complexes decreased 
also, especially at the highest ionic strength.  The size/structure of complexes diluted 
in biological medium indicated that the copolymer imparts stealth properties and 
colloidal and biological stability to the complexes, which could in turn affect the 
clearance properties in vivo. Therefore, these studies could be a rational roadmap for 
designing the optimum complexes/effective nanocarriers for proteins and peptides. 
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INTRODUCTION 
 
Insulin encapsulated within nanoparticles is one of many strategies that have been 
developed in order to enhance the absorption and the bioavailability of the particular 
therapeutic protein, aiming at achieving successful delivery of insulin.1-4 Several 
approaches have been employed in order to realize effective insulin formulations. The 
structural meta- analysis of insulin in pharmaceutical formulations recently appeared 
in the literature.5 An ideal insulin carrier should have reasonably high protein 
encapsulation efficiency and loading capacity, and sustained/controlled release of the 
loaded protein while retaining bioactivity.6,7 
 
Proteins and polyelectrolytes interact, primarily via electrostatic interactions, to form 
hybrid complexes, which can have widely varied stoichiometries, morphologies, 
architectures and shapes. These mixed systems are bio-functional with potential 
applications in the design and development of delivery systems of 
biopaharmceuticals, as well as of biosensors. According to the recent literature, 
polylysine-based block copolymers are effective protein, gene and drug 
nanocarriers.8-12 These mixed materials exhibit both pH and temperature-responsive 
self-assembly and are used as nanocarriers with enhanced properties.13,14  According 
to Lee and Kataoka, ionic biopharmaceuticals, such as genes and proteins can interact 
with ionic block copolymers to form polyion complex micelles with core-shell 
morphology.15 
 
In this investigation, a PEG-polypeptide block copolymer, namely poly(ethylene 
glycol)-block-poly(L-lysine) (PEG-b-PLys) was synthesized and evaluated as INS 
complexing agent. These macromolecules could encapsulate protein molecules in 
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aqueous conditions via electrostatic interactions. In the present work we employ 
dynamic (DLS), static (SLS) and electrophoretic (ELS) light scattering in order to 
examine the complexation process, as well the structure and solution behavior of the 
nanosized complexes in aqueous and biological media, formed between PEG-b-PLys, 
a cationic-neutral block copolymer, and insulin (INS). It should be pointed out that 
PEG polymeric chains are employed as the outer shell of the block copolymer 
micellar type complexes owing to its good water solubility, high degree of 
biocompatibility, and prolonged circulation time in the blood. The main purpose of 
this investigation is to develop macromolecular nanostructures as protein carriers in 
aqueous and biological media and understand aspects of their physicochemical 
behavior. 
 
EXPERIMENTAL  
Materials. INS with a molecular weight of 5800 g/mol was purchased from Sigma 
Aldrich and used without any further purification. Nɛ-(benzyloxycarbonyl)-L-lysine 
N-carboxyanhydride (ZLLys-NCA) was prepared from Z-L-lysine and triphosgene in 
ethyl acetate applying the advanced purification procedure described by Poché and his 
colleagues.16 FTIR (cm-1): 3342 (ν, N–H (NCA, Z)); 2936 (νas, CH2); 2863 (νs, CH2); 
1814, 1774 (ν, C=O (NCA)); 1687 (ν, C = O(Z)); 1533 (δ, N–H(Z); 1258 (δ, C(=O)–
O). The polypeptide-based block copolymer PEG-b-PLys was synthesized by 
controlled ring-opening polymerization of ZLLys-NCA in DMF initiated by primary 
amino-functionalized methoxy-PEG macroinitiator (Mn = 5000 g/mol, purchased from 
Sigma-Adrich). The block copolymer was isolated after precipitation in diethyl ether. 
Due to the copolymer’s amphihpilic character it was purified from unreacted 
macroinitiator by washing of the residue with water/isopropyl alcohol mixture and 
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final product was collected after centrifugation. GPC in DMF (vs. poly(methyl 
methacrylate) standards): Mw/Mn = 1.28. 
1H NMR (DMSO-d6):  δ): 1.10–2.10 (αCH-
(CH2)3),  2.95 (αCH-(CH2)3-CH2),  3.23 (CH3O); 3.51 (O-CH2-CH2-O + O-CH2CH2-
NH), 3.90-4.30 (αCH-NH), 4.98 (Z-CH2), 6.83–7.41 (αCH-(CH2)4-NH + C6H5), 7.89–
8.19 (αCH–NH). FTIR (cm-1): 3318 (ν, N–H (NCA, Z); 1697 (ν, C=O(Z); 1651 (ν, 
C=O (amide I); 1537 (δ, N-H(Z) (amide II), 1103 (ν, C-O-C (ether). 
 The block copolymer was dissolved in trifluoroacetic acid and was treated with HBr 
(33 wt.% in acetic acid) to remove the benzyloxycarbonyl protecting groups from the 
peptide units. 1H NMR (D2O):  δ): 1.30-1.95 (αCH-(CH2)3); 3.02 (αCH-(CH2)3CH2); 
3.40 (CH3O); 3.72 (O-CH2-CH2 + O-CH2CH2-NH), 4.33 (αCH-NH). The number 
average degree of Lys polymerization determined by 1H NMR analysis is 13 (approx. 
35 wt % Lys units in the block copolymer, Figure S1) The structure of PEG-b-PLys is 
presented in Fig. 1(a).  
 
 
 
Figure 1: (a) Molecular structure of PEG-b-PLys polyelectrolyte block copolymer 
and (b) schematic representation of the formation of PEG-b-PLys:INS complexes. 
a. 
b. 
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Preparation of PEG-b-PLys:INS polyelectrolyte aggregates in different aqueous 
media. A pH 7 buffer solution was prepared from NaOH and 5mM sodium 
phosphate, Moreover, 10mM NaCl were added to solution to maintain a fixed ionic 
strength, along with NaN3 in a final concentration of 200 ppm, in order to avoid 
bacterial growth. Stock solutions of INS and of PEG-b-PLys were prepared by 
dissolving a weighed amount of the dialyzed sample in the appropriate volume of the 
buffer and the solutions were left to stand overnight for better equilibration. Stock 
solutions of insulin (1mg/ml) and polyelectrolyte in 0.01M pH=7.10 (Tris buffer) 
were also prepared.10,17  
The complexes were prepared by adding different amounts of the INS solutions to 
PEG-b-PLys solutions of the same volume and concentration, under stirring. Finally, 
appropriate volumes of buffer solutions were added to achieve a constant final volume 
and ionic strength (equal to that of the buffer solutions) for all solutions prepared. 
Thus, the concentration of PEG-b-PLys was kept constant throughout the series of 
solutions, while that of INS varied in order to control the required ratio of the two 
components (or equivalently the [-]/[+] charge ratio of the mixture). The solutions of 
the complexes developed a bluish tint or turbidity upon mixing, indicating the 
formation of supramolecular complexes. Subsequently, the solutions of the complexes 
were left for equilibration overnight, which in some cases resulted in coacervation, i.e. 
liquid-liquid phase separation of the solution, depending on the INS concentration and 
pH. Stable solutions were further characterized as discussed below. 
For the ionic strength dependent light scattering measurements, the ionic strength of 
the solution was gradually increased by the addition of appropriate aliquots of 1N 
NaCl solution at pH=7.00, pH=7.10 (Tris buffer) or 7.40 (PBS), to 1ml of the 
previously prepared solutions of the complexes. After each addition the solution was 
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rigorously stirred and left to equilibrate for 15min before measurement. Changes in 
solute concentrations due to NaCl solution addition were taken into consideration in 
the analysis of the light scattering data.    
Insulin encapsulation efficiency. The loading of insulin into complexes was 
investigated by dialysis method. Hybrid nanovectors incorporating INS (3ml of each 
sample) were placed in dialysis sacks (molecular weight cut off 12,000; Sigma-
Aldrich). Dialysis sacks were inserted in 30 mL PBS in shaking water bath, set at 25 
oC (room temperature), for 2 hours. This protocol was found to give consistent results 
as supported by triplicate dialysis experiments. The percentage of INS incorporated 
into complexes was estimated by spectrophotometry.  INS concentration was 
estimated with the aid of the following INS calibration curve in PBS (pH=7.4): 
INS concentration (
mg
ml⁄ ) =
absorbance − 0.0213
0.2822
  (R2 = 0.9966) (𝟏) 
The absorbance was measured at 277nm. Encapsulation efficiency (EE) was 
calculated by using the following equation: 
%𝐸𝐸 =
𝑡𝑜𝑡𝑎𝑙 𝑎𝑚𝑜𝑢𝑛𝑡 𝑜𝑓 𝐼𝑁𝑆 − 𝑓𝑟𝑒𝑒 𝐼𝑁𝑆
𝑡𝑜𝑡𝑎𝑙 𝑎𝑚𝑜𝑢𝑛𝑡 𝑜𝑓 𝐼𝑁𝑆 (𝑖𝑛𝑖𝑡𝑖𝑎𝑙)
× 100 (𝟐) 
All samples were measured in triplicate and are reported as the mean value. 
Dynamic and static light scattering. The hydrodynamic radius (Rh) of 
polyelectrolyte nanocarriers and the size polydispersity index (PD.I.) were determined 
by dynamic light scattering (DLS). Mean values and standard deviations were 
calculated on three independently prepared samples. For dynamic and static light 
scattering measurements, an AVL/CGS-3 Compact Goniometer System (ALV GmbH, 
Germany) was used, equipped with a cylindrical JDS Uniphase 22mV He-Ne laser, 
operating at 632.8 nm, and an Avalanche photodiode detector. The system was 
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interfaced with an ALV/LSE-5003 electronics unit, for stepper motor drive and limit 
switch control, and an ALV-5000/EPP multi-tau digital correlator.  Autocorrelation 
functions were analyzed by the cumulants method and the CONTIN software. 
Apparent hydrodynamic radii, Rh, at finite concentrations, were calculated by aid of 
the Stokes - Einstein equation: 
𝑅ℎ =  
𝑘𝐵𝑇
6𝜋𝑛0𝐷
  (𝟑) 
where kB is the Boltzmann constant, η0 is the viscosity of water at temperature T, and 
D is the diffusion coefficient at a fixed concentration. The polydispersity of the 
particle sizes was given as the 
𝜇2
𝛤2⁄
 (PD.I.) from the cumulants method, where Γ is 
the average relaxation rate, and μ2 is its second moment. 
Static light scattering has been used in order to estimate the radius of gyration, Rg, of 
the chimeric nanoassemblies via the use of Zimm plots, which can be described by the 
following equation: 
 (
𝐾𝐶
𝑅𝑉𝑉(𝑞)
)
𝑐→0
≅
1
𝑀𝑊
(1 +
1
3
𝑅𝑔
2𝑞2) (𝟒)  
where Rvv(q) is known as the Rayleigh ratio, 
2 2 2 4
A 04 ( / ) ( )K n dn dC N   and 
0(4 / )sin( / 2)q n   , with NA, dn/dC, n and λ0 being the Avogadro number, the 
specific refractive index increment, the solvent refractive index, and the wavelength 
of the light in vacuum, respectively. Measurements were made at the angular range of 
30º to 150º. Toluene was used as the calibration standard for obtaining absolute 
values for the scattered intensity. These values were subsequently utilized for the 
estimation of Rg/Rh ratios which are indicative of the shape of the nanoassemblies.  
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Electrophoretic Light Scattering-Zeta potential measurements. Electrophoretic 
Light Scattering is a technique used to measure the electrophoretic mobility of hybrid 
nanostructures. The fundamental physical principle is that of electrophoresis. A 
dispersion/solution is introduced into a cell containing two electrodes. An electrical 
field is applied to the electrodes, and particles that have a net charge, or more strictly 
a net zeta potential, will migrate towards the oppositely charged electrode with a 
velocity, known as the electrophoretic mobility, that is related to their zeta potential 
values. The zeta potential of nanostructures was measured using Zetasizer 3000HAS, 
Malvern Instruments, Malvern, UK. 50μl of the solutions of the block 
copolymer/protein complexes was 30-fold diluted in buffer and ζ-potential was 
measured at room temperature at 633nm. The zeta potentials were calculated from 
electrophoretic mobilities, μΕ, by using the Henry correction of the Smoluchowski 
equation: 
𝜁 =
3𝜇𝛦𝑛
2𝜀0 𝜀𝑟
1
𝑓(𝜅𝑎)
  (𝟓) 
where 𝜀0 is the permittivity of the vacuum, 𝜀𝑟 is the relative permittivity, α is the 
particle radius, κ is the Debye length, and n is the viscosity of water. The function 
f(κα) depends on particle shape. While if κα > 1: 
𝑓(𝜅𝛼) = 1.5 +
9
2(𝜅𝛼)
+
75
2(𝜅𝛼)2
  (𝟔) 
The above function refers to dispersions of the present study.  
Results and Discussion 
Physicochemical and structural characterization of PEG-b-PLys:INS complexes 
in aqueous  media. The complexation process between the PEG-b-PLys 
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polyelectrolyte and INS at pH=7, pH=7.1 and at pH=7.4 was first investigated by 
means of dynamic light scattering.  It should be noted that PBS (pH=7.4) was chosen 
as dispersion medium because the pH and the ionic strength of PBS resembles the 
physiological conditions of human body. At pH=7 the electrostatic interactions of the 
system are expected to be strong, since the PEG-b-PLys polyelectrolyte block carries 
thirteen (+13) positively charged groups per chain (number of lysine amine 
functionalized monomeric units, Figure 1(a) and INS has a net negative charge of -4. 
The distributions of hydrodynamic radius (Rh) for INS and PEG-b-PLys exhibit some 
differences in the different aqueous media, while the Rh were more or less the same.  
The obtained results from DLS measurements at 90° regarding the values of the light 
scattering intensity, I90, and hydrodynamic radius, Rh, are shown in Figures 2(a) and 
(d), as a function of the protein concentration, CINS, in the solutions of the complexes. 
The structure and the formation process of complexes is schematically represented in 
Fig.1(b). The concentration of PEG-b-PLys copolymer is kept constant throughout the 
series of aqueous solutions of different ionic strength investigated. DLS results at low 
ionic strength (0.01M) at pH=7 show that all solutions exhibit a main peak at high Rh 
values (ca. 60nm) at low concentration of INS, which apparently corresponds to the 
formed mixed aggregates (Fig. 2(a)).  An increase of Rh values was observed as the 
concentration of INS was increased. These solutions exhibit a main peak at high Rh 
values (~120nm at the highest concentration of INS) (Fig. 2(a)). Furthermore, DLS 
results at low ionic strength (0.01M) at pH=7.10 show that all solutions exhibit a main 
peak at high Rh values (~40nm) at low concentration of INS, which apparently 
corresponds to the formed mixed aggregates (Fig. 2(a)). On the other hand, a decrease 
Rh values was observed at the increased concentration of INS, and these suspensions 
exhibited a main peak at ~30nm. The Polydispersity Index (PD.I.) values indicate 
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quite monodisperse colloidal formulations, especially for the dispersions at low ionic 
strength (0.01M) and at high INS concentrations (Fig. 2(b)). ζ- potential remained 
unaffected as the concentration of the INS increases (Fig. 2(c)).   The values of the 
scattering intensity, I90, which is proportional to the mass of the species in solution, 
increased gradually as a function of CINS, providing proof of the occurring 
complexation (Fig.2(d)), i.e. the mass of the complexes increases as CINS increases. 
As INS concentration increases each polyelectrolyte chain interacts with an increasing 
number of INS molecules, the degree of charge neutralization becomes higher and the 
size distribution of the complexes decreased also, especially at the highest ionic 
strength. In contrast I90 (and mass of the complexes) remains almost constant in the 
case of PBS solutions (Fig. 2(d)). On the other hand, the ζ-potential values increased 
in absolute value as the concentration of the INS increases, in PBS (Fig. 2(c)), and 
become more negative. Additionally, the Rh did not changed significantly as the 
concentration of INS was increased, while the population of the colloidal 
nanoparticles became more homogeneous (Fig. 2(b)).  Taking into consideration the 
greater ionic strength of PBS one can assume that the above observations may be due 
to increased screening of effects on the electrostatic interactions between the 
components of the complexes. The mass of the complexes is significantly higher at 
pH=7 and I=0.01M, showing increased interactions, while the size of the complexes is 
constantly larger in PBS, showing more swelled structures under the latter conditions. 
Another synergistic phenomenon that could contribute to the above phenomenology is 
the different solvation of PEG polymeric chains.18 These differences in the hydration 
energy of the water molecules make the PEG polymeric chain more hydrophilic. The 
presence of ions plays a key role for the improved hydration of PEG chains due to the 
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screening effects in the interactions between the water molecules and the PEG 
polymeric chains.19-20   
The morphology of nanovectors is quite important for their biological behavior and 
pharmacokinetic profile of the encapsulated bioactive compound.21-24 The values of 
Rg/Rh were also calculated and presented in Fig 2.(e).  This ratio is sensitive to the 
shape/morphology of nanoparticles/ nanoparticulate complexes in dispersion and can 
be used as a rough estimate of the internal morphology of the colloidal particle. This 
is based on the notion that Rh defines the outer dimensions of the particle while Rg is a 
measure of the mass density distribution around the center of the nanostructure. 
According to Burchard, the ratio Rg/Rh takes the values of 0.775 for a hard uniform 
sphere and 1.0 for vesicles with thin walls, while values of 1.3 to 1.5 indicate a 
random coil (loose) conformation in the case of macromolecular chains.25 In the 
present case, the values Rg/Rh
 are in the range 0.80-1.00 for  PEG-b-PLys:INS at low 
ionic strength (I=0.01M) and pH=7, indicating a more well-defined spherical, rather 
dense nanostructure for the complexes (Fig 2.(e)). On the other hand, the values Rg/Rh 
indicate open (low density) spherical structures for the complexes or a rather low 
density full spherical structure in PBS (Fig 2.(e)). The differences of the external 
morphology of complexes indicate that the dispersion medium plays a key role on the 
electrostatic interactions and the hydration of the hydrophilic PEG chains, due to the 
different ionic strength of the aqueous dispersion media. In other words, the 
physicochemical characteristics of the prepared complexes are strongly influenced by 
the dispersion medium (salinity, pH, ionic strength).  
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Fig. 2. (a) Hydrodynamic radius, Rh, (b) Polydispersity Index, (PD.I.), (c) ζ-potential, 
(d) light scattering intensity at 90°, I, and (e) Rg/Rh as a function of CINS, for the 
solutions of PEG-b-PLys:INS complexes formed at pH=7 and 0.01M NaCl 
(diamonds), pH=7.1 and 0.01M (Tris buffer) (triangles) and at pH=7.4 and 0.154M 
NaCl (squares).  
 
The encapsulation efficiency of the PEG-b-PLys complexes in PBS was also 
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different formulation as seen in Figure 3. They were particularly affected by the initial 
concentration of INS. Encapsulation efficiency increased with the increase of the 
initial concentration of the protein in PBS (Figure 3). The insulin encapsulation 
efficiency of these hybrid nanosystems increased at the isoelectric point, where the 
zeta potential exhibited a shift to negative values (Figure 3 and Fig. 2.(c))26,27 The 
higher encapsulation efficiency was observed when the initial concentration of insulin 
was CINS=0.133mg/ml ([-]/[+] charge ratio equal to 1). At higher concentration of 
insulin the ζ-potential of complexes became more negative, and this observation 
indicated that there is repletion in the complexation process/ encapsulation efficiency 
after the charge equilibration point.  This observation may indicate a difference in the 
internal structure of the complexes at different protein/copolymer ratios. It should be 
pointed out that the nanocarriers did not release the protein until four hours. In our 
opinion, this observation is correlated to the strong electrostatic interactions between 
the protein and the PLys block of the block polyelectrolyte. 
 
Fig. 3: Encapsulation efficiency (%) of INS in PEG-b-PLys:INS complexes in PBS, 
as a function of the initial concentration of INS. 
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Physicochemical characterization of preformed PEG-b-PLys:INS complexes in 
biological medium (FBS). It is of great importance for the clinical application to 
characterize the physicochemical properties of the nanostructures in biological media, 
like FBS, because interaction with plasma proteins of the medium (especially 
albumin) is expected to alter the physicochemical and morphological properties of the 
colloidal nanostructures, thereby affecting their stability and clearance/biodistribution 
properties.28  
The prepared complexes in aqueous media were diluted in FBS:PBS 10%/90% v/v, in 
order to investigate the properties of the hybrid complexes in a biological medium. 
The size of the complexes in biological medium (FBS) are presented in Figs. 4(a) and 
5(a). The size of the complexes in FBS decreased by 10 to 25nm, for the complexes 
prepared in the two different aqueous media, while the reduction of the scattering 
intensity was larger in comparison to aqueous media. The obtained results indicate the 
disintegration of the supramolecular aggregates due to the interaction of the 
components (PEG-b-PLys and insulin) with the serum components, especially with 
the albumin. After the dilution of the complexes in FBS:PBS 10%/90% v/v, the 
insulin/PEG-b-PLys hydrid nanostructured exhibited different physicochemical 
characteristics. In all cases, the supramolecular aggregates of insulin carrier 
complexes and plasma proteins remained at the nanoscale (smaller than 100nm). In 
some cases, the observed decrease of the Rh may be due to the interactions of FBS 
albumins with insulin/PEG-b-PLys complexes, leading to changes in their size, via 
components redistribution and partial disruption of the initial complexes. This 
observation indicates that PEG-b-PLys copolymer partially imparts stealth properties 
and biological stability in the complexes, due to the presence of PEG polymeric 
chains that shield the nanostructures. A shift of ζ-potential to negative values is 
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observed presumably due to some binding of FBS proteins, which can alter the 
nanoparticle’s effective size, hydration and surface properties (the main protein 
component of FBS is albumin which carries a negative charge at physiological 
conditions).29,30 We should point out that the ζ-potential of FBS:PBS 10%/90% v/v 
biological medium is equal to -10mV, while the albumin exhibits -18 negative 
charges. As a result, in the dispersion, after the dilution in FBS:PBS 10%/90% v/v, 
serum protein/PEG-b-PLys/insulin complexes, and free serum proteins may be 
present and influence the values of zeta-potential. However, only one broad peak in 
electrophoretic mobility was observed, so it is difficult to make any additional 
conclusions on the present systems. Subsequently, there is a significant decrease in 
the scattered intensity from the protein–PEG-b-PLys:INS clusters (Figs. 4(b) and 5(b). 
Alterations in scattering intensity should be attributed to changes in the mass of the 
species (colloidal polymeric nanoparticles and complexed components of FBS) and/or 
changes in the relative amounts of the supramolecular aggregates. The results seem to 
point also toward a change in the internal structure of  PEG-b-PLys:INS due to the 
limited  interaction (possible absorption and incorporation) of serum proteins and 
their aggregation.  
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Fig. 4. (a) Hydrodynamic Radius, Rh and (b) light scattering intensity at 90°, I, as a 
function of CINS, for the solutions of PEG-b-PLys:INS complexes prepared at pH=7 
and I=0.01M, diluted in FBS:PBS 10%/90% (v/v). 
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Fig. 5. (a) Hydrodynamic radius, Rh and (b) light scattering intensity at 90°, as a 
function of CINS, for the solutions of PEG-b-PLys:INS complexes prepared at pH=7.4 
and I=0.154M, and diluted in FBS:PBS 10%/90% (v/v). 
 
Effect of ionic strength on the physicochemical characteristics of preformed 
PEG-b-PLys:INS complexes.  
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eventually causes the aggregation of the preformed complexes. This effect arises from 
the induced charge screening that weakens the electrostatic interactions of the 
systems.  
0
50
100
150
200
250
0.00 0.10 0.20 0.30 0.40 0.50
R
h
(n
m
)
CINS (mg/ml)
0
500
1000
1500
2000
2500
3000
0.00 0.10 0.20 0.30 0.40 0.50
I 
(k
H
z)
CINS (mg/ml)
a. 
b. 
19 
 
The increase of the ionic strength in the solutions of the complexes induces charge 
screening and weakening of the electrostatic interactions, so it is expected to greatly 
influence the solution behavior and structure/morphology of the performed 
complexes. In order to investigate this effect, DLS measurements as a function of the 
added NaCl concentration were conducted, and the resulting I90 (corrected for the 
difference in concentration) and Rh values for representative solutions at low and high 
CINS values of PEG-b-PLys:INS system at pH 7.00, pH=7.10 and 7.40 are shown in 
Figs. 6., 7. and 8.  At pH 7.00 and pH=7.10, the dispersions of the complexes exhibit 
more or less the same response (same size, Rh values) to the increase of the ionic 
strength, apparently due to the particular structure of the formed complexes in each 
solution (Figs. 6(a). and 7(a).).   The scattering intensity decreased significantly (Figs. 
6(b) and 7(b)) and this trend was independent of the initial concentration of the 
insulin. As mentioned previously, at low CINS values the number of interacting INS 
molecules per polyelectrolyte chain is rather small, while at high CINS values the 
formed complexes are characterized by rather large number of interacting INS 
molecules per polyelectrolyte chain. Respectively, an abrupt increase of the mass of 
the complexes is observed at higher CINS upon addition of the salt at both aqueous 
media (Figs. 6b and 7b). The Rh of the INS complexes, as a function of INS 
concentration, increased slightly in the case of PBS buffer (Fig. 8(a)), while the 
scattering intensity decreased significantly (Fig. 8(b)).31,32  
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Fig. 6. (a) Hydrodynamic Radius, Rh, and (b) light scattering intensity at 90°, I, as a 
function of the added NaCl concentration of representative solutions (0.067mg/ml –
diamonds, 0.200mg/ml – squares and 0.400mg/ml –triangles), corresponding to low 
and high CINS, of the PEG-b-PLys:INS complexes prepared at pH=7 and I=0.01M.  
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Fig. 7. (a) Hydrodynamic Radius, Rh,  and (b) light scattering intensity at 90°, I, as a 
function of the added NaCl concentration of representative solutions, corresponding 
to low and high CINS, (0.067mg/ml –diamonds, 0.200mg/ml – squares and 
0.400mg/ml –triangles),of the PEG-b-PLys:INS complexes prepared at pH=7.1 (Tris 
buffer).   
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Fig. 8. (a) Hydrodynamic Radius, Rh, and (b) light scattering intensity at 90°, I, as a 
function of the added NaCl concentration of representative solutions, corresponding 
to low and high CINS, (0.067mg/ml –diamonds, 0.200mg/ml – squares and 
0.400mg/ml –triangles), of the PEG-b-PLys:INS complexes prepared at pH=7.4 and 
I=0.154M (PBS buffer).   
 
CONCLUSIONS 
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polyelectrolyte copolymer is kept constant throughout the series of aqueous solutions 
of different ionic strength investigated. The physicochemical and structural 
characteristics of the complexes depend on the ionic strength of the aqueous medium.  
The values of the scattering intensity, I90, which is proportional to the mass of the 
species in solution, increase gradually as a function of CINS, providing proof of the 
occurring complexation. The size of complexes in biological medium (FBS) was not 
increased significantly. This observation indicates that the copolymer imparts stealth 
properties and biological stability to the complexes, which could affect the clearance 
properties in vivo. The selection of the buffer (aqueous medium) for formulating 
insulin/PEG-b-PLys complexes is a crucial parameter, because it affects the 
complexation process, the physicochemical characteristics, the internal/external 
morphology, the biological behavior and the effects of salinity on the preformed 
hybrid block copolymer/protein nanostructures. In conclusion, this study provides 
interesting and useful new insights into the interaction mechanism between oppositely 
charged block polyelectrolyte and INS resulting in formation of aggregates with 
stealth properties, and could be a roadmap in order to select the aqueous medium to 
achieve the desired properties of the nanocarriers.  
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